Global Human Insulin Market $34.4 Billion by 2021

According to a market research report Human Insulin Market Analysis and Forecast 2017-2021 published by iHealthcareAnalyst, Inc., the global human insulin market is estimated to reach $34.4 Billion in 2021, expanding at a CAGR of 4.8% from 2017 to 2021.

The human insulin market report estimates the market size (Revenue $million - 2014 to 2021) and composition of this market in terms of five product classes such as slow-acting, fast-acting, long-acting, intermediate-acting and premixed insulin and forecasts growth trends (CAGR% - 2017 to 2021). It also covers the major competitors operating in the market and provides a bird’s eye view of the different insulin analogs available in the global market.
The global human insulin market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.

Visit the Human Insulin Market Analysis and Forecast 2017-2021 report at https://www.ihealthcareanalyst.com/report/insulin-market/

1. Source
1.1. Human
1.2. Recombinant

2. Mode of Action
2.1. Slow-Acting (Basal) Analogs
2.2. Fast-Acting Analogs
2.2.1. Pipeline Analysis
2.2.1.1. Afrezza
2.2.1.2. NN1218 (FIAsp)
2.3. Long-Acting Analogs
2.3.1. Pipeline Analysis
2.3.1.1. IDegLira (Xultophy)
2.3.1.2. LY2605541(Novel Basal Insulin Analog)
2.3.1.3. LY2963016 (Long Acting Basal Insulin)
2.3.1.4. MK-1293 (Sustained Release Insulin Analog)
2.3.1.5. U-300 (Toujeo)
2.4. Intermediate-Acting Analogs
2.5. Premixed Insulin

3. Company Profiles
3.1. Eli Lilly and Company
3.2. Novo Nordisk A/S
3.3. Sanofi
3.4. Thermalin Diabetes, LLC

To request Table of Contents and Sample Pages of this report visit:
https://www.ihealthcareanalyst.com/report/insulin-market/

iHealthcareAnalyst, Inc. is a global health care market research and consulting company providing market analysis, and competitive intelligence services to global clients. The Company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.

iHealthcareAnalyst, Inc. provides industry participants and stakeholders with strategically analyzed, unbiased view of market dynamics and business opportunities within its coverage areas.

iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Email: sales@ihealthcareanalyst.com
Website: https://www.ihealthcareanalyst.com

This release was published on openPR.